Supplemental material
Drug Delivery
Volume 24, 2017 - Issue 1
Related Research Data
Inclusion complex of barbigerone with hydroxypropyl-β-cyclodextrin: Preparation and in vitro evaluation
Source:
Elsevier BV
Concepts and practices used to develop functional PLGA-based nanoparticulate systems
Source:
Informa UK Limited
Formulation, characterization and evaluation of cyclodextrin-complexed bendamustine-encapsulated PLGA nanospheres for sustained delivery in cancer treatment.
Source:
Informa UK Limited
Nanoparticles: Emerging carriers for drug delivery.
Source:
Elsevier BV
Fisetin inhibits various attributes of angiogenesis in vitro and in vivo—implications for angioprevention
Source:
Oxford University Press (OUP)
Anticancer Activity of a Combination of Cisplatin and Fisetin in Embryonal Carcinoma Cells and Xenograft Tumors
Source:
American Association for Cancer Research (AACR)
Inclusion complex with cyclodextrins enhances the bioavailability of flavonoid compounds: a systematic review
Source:
Springer Science and Business Media LLC
Complexation of fisetin with novel cyclosophoroase dimer to improve solubility and bioavailability.
Source:
Elsevier BV
Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy.
Source:
Elsevier BV
Fabrication, characterization and bioevaluation of silibinin loaded chitosan nanoparticles
Source:
Elsevier BV
Bombesin-conjugated nanoparticles improve the cytotoxic efficacy of docetaxel against gastrin-releasing but androgen-independent prostate cancer.
Source:
Future Medicine Ltd
Fisetin-loaded nanocochleates: formulation, characterisation, in vitro anticancer testing, bioavailability and biodistribution study
Source:
Informa Healthcare
Enhanced Oral Bioavailability of Paclitaxel Formulated in Vitamin E-TPGS Emulsified Nanoparticles of Biodegradable Polymers: In Vitro and In Vivo Studies
Source:
Elsevier BV
Linking provided by
